ZA985704B - Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease - Google Patents

Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Info

Publication number
ZA985704B
ZA985704B ZA985704A ZA985704A ZA985704B ZA 985704 B ZA985704 B ZA 985704B ZA 985704 A ZA985704 A ZA 985704A ZA 985704 A ZA985704 A ZA 985704A ZA 985704 B ZA985704 B ZA 985704B
Authority
ZA
South Africa
Prior art keywords
diagnosis
prevention
compositions
surface antigens
lyme disease
Prior art date
Application number
ZA985704A
Other languages
English (en)
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of ZA985704B publication Critical patent/ZA985704B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA985704A 1997-06-30 1998-06-30 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease ZA985704B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30

Publications (1)

Publication Number Publication Date
ZA985704B true ZA985704B (en) 1999-01-13

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985704A ZA985704B (en) 1997-06-30 1998-06-30 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease

Country Status (17)

Country Link
US (2) US6660274B2 (fr)
EP (1) EP1012181B1 (fr)
JP (1) JP2002511760A (fr)
KR (1) KR20010020567A (fr)
CN (1) CN1261896A (fr)
AR (1) AR016295A1 (fr)
AT (1) ATE337335T1 (fr)
AU (1) AU8177298A (fr)
CA (1) CA2294701C (fr)
CO (1) CO4790101A1 (fr)
DE (1) DE69835682T2 (fr)
DK (1) DK1012181T3 (fr)
ES (1) ES2270523T3 (fr)
NO (1) NO996514L (fr)
PL (1) PL337667A1 (fr)
WO (1) WO1999000413A1 (fr)
ZA (1) ZA985704B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1589109B1 (fr) * 1996-02-21 2017-04-12 Board of Regents, The University of Texas System Séquences de Borrelia pathogènes semblables à une pmv
US6660274B2 (en) * 1997-06-30 2003-12-09 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
WO2004058181A2 (fr) 2002-12-20 2004-07-15 Board Of Regents, The University Of Texas System Sequences d'especes et de souches de borrelia pathogene de type vmp
WO2007133623A2 (fr) * 2006-05-10 2007-11-22 Biopeptides Corporation Agent de diagnostic peptidique pour la maladie de lyme
UA99719C2 (ru) 2006-11-03 2012-09-25 Шеринг-Плау Лтд. Вакцина для собак против болезни лайма
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
EP2191266A4 (fr) * 2007-09-07 2011-08-03 Univ California Procédés de diagnostic et de criblage concernant borrelia
WO2010132758A2 (fr) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Test de diagnostic à base de ospc pour la maladie de lyme
EP2501719B1 (fr) 2009-11-17 2015-11-04 Abaxis, Inc. Peptides et procédés pour la détection d'anticorps contre la maladie de lyme
AU2011252844B2 (en) 2010-05-14 2014-07-03 Baxalta GmbH Chimeric OspA genes, proteins, and methods of use thereof
CN103229055A (zh) 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
WO2013067448A2 (fr) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions et procédés de détection de divers organismes infectieux
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
WO2016049148A1 (fr) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions et méthodes de diagnostic de la maladie de lyme
CN108351355A (zh) 2015-08-27 2018-07-31 奎多公司 具有两个流体流动路径用于检测和区分两个或多个分析物的免疫分析测试设备
CN108139401B (zh) * 2015-09-25 2022-02-18 凯杰科技有限公司 诊断莱姆病并用于预测治疗后莱姆病螺旋体消除的组合物和方法
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CA3053110A1 (fr) 2017-02-10 2018-08-16 Quidel Corporation Dosage a ecoulement lateral utilisant un substrat comportant des canaux pour reguler un ecoulement de fluide
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (fr) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen Procédé de préparation d'un conjugué antigénique ou immunogénique ainsi que l'utilisation de tels conjugués
DK0506868T4 (da) 1989-12-22 2004-04-26 Mikrogen Molekularbiol Entw Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
JPH05501113A (ja) 1990-03-05 1993-03-04 アメリカ合衆国 ボレリア　ブルグドルフェリの抗原性タンパク質
CA2084413A1 (fr) 1990-06-15 1991-12-16 Richard A. Flavell Compositions et methodes pour la prevention et le diagnostic de la maladie de lyme
EP1016416A3 (fr) * 1990-07-06 2002-10-23 Wyeth Vaccin contre la maladie de lyme et modèle pour l'évaluation de l'efficacité du vaccin
EP1589109B1 (fr) 1996-02-21 2017-04-12 Board of Regents, The University of Texas System Séquences de Borrelia pathogènes semblables à une pmv
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
US6660274B2 (en) * 1997-06-30 2003-12-09 The Administrators Of The Tulane Educational Fund Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
AU8177298A (en) 1999-01-19
ATE337335T1 (de) 2006-09-15
ES2270523T3 (es) 2007-04-01
AR016295A1 (es) 2001-07-04
DE69835682T2 (de) 2007-08-23
NO996514D0 (no) 1999-12-28
NO996514L (no) 2000-02-14
US20040067517A1 (en) 2004-04-08
KR20010020567A (ko) 2001-03-15
DE69835682D1 (de) 2006-10-05
JP2002511760A (ja) 2002-04-16
US6660274B2 (en) 2003-12-09
CA2294701A1 (fr) 1999-01-07
CN1261896A (zh) 2000-08-02
CA2294701C (fr) 2009-09-08
PL337667A1 (en) 2000-08-28
CO4790101A1 (es) 1999-05-31
EP1012181A1 (fr) 2000-06-28
EP1012181B1 (fr) 2006-08-23
US20030059894A1 (en) 2003-03-27
DK1012181T3 (da) 2007-01-02
WO1999000413A1 (fr) 1999-01-07

Similar Documents

Publication Publication Date Title
ZA985704B (en) Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease
ZA989461B (en) Methods and compositions for the treatment of autoimmune disease using heat shock proteins
EP0727225A3 (fr) Compositions et méthodes pour l'imagerie ultrasonique dirigée
IL195649A0 (en) Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
SG47447A1 (en) Compositions and methods for the prevention and diagnosis of lyme disease
ZA9810130B (en) Tumor-specific antigens methods for their production and their use for imunization and diagnosis
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
GB9806666D0 (en) Antigen preparation and use
GB9809696D0 (en) Improvements in or relating to the formation of images
EP0934427A4 (fr) Compositions d'antigenes du groupe sanguin rh et procedes d'utilisation
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
PT1025100E (pt) Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
IL118407A0 (en) Polymyxin dextran conjugates their preparation and pharmaceutical compositions containing them
EP0987942A4 (fr) Composition pharmaceutique et procede d'utilisation
AU7836798A (en) Compositions for delivery of biological agents and methods for the preparation thereof
AU3665699A (en) Compositions and methods for tolerization in immune complex-mediated disease progression
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
GB9515754D0 (en) Compositions and methods for the prevention of symptoms of viral disease
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders